Diazoxide-Induced Hypertrichosis in a Neonate With Transient Hyperinsulinism

Diazoxide is one of the FDA-approved pharmacologic treatments for hyperinsulinemic hypoglycemia, however, its adverse effects in infants are not well described. We reported a 37-week-old boy with the diagnosis of hypoglycemia. We started a dextrose infusion, but we used oral diazoxide, due to hypogl...

Descripción completa

Detalles Bibliográficos
Autores principales: Boskabadi, Seyyed Javad, Ramezaninejad, Sima, Sohrab, Masoumeh, Farhadi, Roya
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2023
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885027/
https://www.ncbi.nlm.nih.gov/pubmed/36726424
http://dx.doi.org/10.1177/11795476231151330

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9885027/
https://www.ncbi.nlm.nih.gov/pubmed/36726424
http://dx.doi.org/10.1177/11795476231151330

Ejemplares similares